[Federal Register Volume 68, Number 68 (Wednesday, April 9, 2003)]
[Notices]
[Pages 17402-17403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-8583]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 14, 2003, Boehringer 
Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application by renewal, and on November 27, 2002, made 
application by renewal, and on November 27, 2002, made application by 
letter to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Methylphenidate (1724).....................  II
Levo-aphacetylmethadol (9648)..............  II
Fentanyl (9801)............................  II
Dextropropoxphene (9273)...................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
formulation into finished pharmaceuticals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.

[[Page 17403]]

    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537; Attention: Drug Operations Section, Domestic Drug 
Unit (ODOD) and must be filed no later than June 9, 2003.

    Dated: March 21, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-8583 Filed 4-8-03; 8:45 am]
BILLING CODE 4410-09-M